Nippon India Pharma Fund vs DSP Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹8161 Cr | ₹3198 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 05 Jun 2004 | 30 Nov 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 18% |
Expense Ratio | 1.82 | 1.9 |
Manager | Sailesh Raj Bhan | Jay Kothari |
ISIN Code | INF204K01968 | INF740KA1LD8 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Month | -6% | -6.61% |
6 Month | -8.47% | -0.59% |
1 Year | 6.77% | 15.26% |
3 Year | 18.71% | 21.12% |
5 Year | 22.93% | 25.01% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
6 Month | - | - |
1 Year | -1.87% | 5.87% |
3 Year | 21.17% | 25.18% |
5 Year | 19.06% | 21.74% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Year | 18.19% | 28.82% |
3 Year | 20.5% | 20.72% |
5 Year | 20.36% | 27.72% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Standard Deviation | 15.185% | 15.136% |
Sharp | 0.81% | 0.954% |
Beta | 0.931% | 0.893% |
Alpha | -0.33% | 2.305% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Name | Sailesh Raj Bhan | Jay Kothari |
Total AUM | ₹96086 Cr | ₹0 Cr |
Fund Manage | 5 | 20 |
Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 4.4 | 17.61 |
Large Cap | 45.96 | 22.07 |
Mid Cap | 27.12 | 18.45 |
Small Cap | 22.52 | 41.87 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 4.4 | 17.61 |
Pharmaceuticals & Biotechnology | 75.86 | 68.54 |
Healthcare Services | 17.38 | 11.97 |
Retailing | 2.36 | 0.41 |
Insurance | - | 1.47 |
Top Comparisons
HDFC Multi-Asset Fund - Growth Option
3Y Returns12.08%
Motilal Oswal Multi Asset Fund - Regular Plan - Growth Option
3Y Returns2.56%
Tata Treasury Advantage Fund - Regular Plan - Growth Option
3Y Returns6.27%
Canara Robeco Savings Fund - Regular Plan - Growth Option
3Y Returns6.27%
Franklin Build India Fund Growth Plan
3Y Returns25.26%
Tata Infrastructure Fund-Regular Plan- Growth Option
3Y Returns18.62%
Canara Robeco CorpoRate Bond Fund - Regular Plan - Growth Option
3Y Returns5.53%
Axis Corporate Bond Fund - Regular Plan Growth
3Y Returns6.32%